FR3896M - - Google Patents

Info

Publication number
FR3896M
FR3896M FR944790A FR944790A FR3896M FR 3896 M FR3896 M FR 3896M FR 944790 A FR944790 A FR 944790A FR 944790 A FR944790 A FR 944790A FR 3896 M FR3896 M FR 3896M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR944790A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR3896M publication Critical patent/FR3896M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Transmission Devices (AREA)
FR944790A 1962-05-15 1963-08-11 Expired FR3896M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19497262A 1962-05-15 1962-05-15

Publications (1)

Publication Number Publication Date
FR3896M true FR3896M (fr) 1966-02-07

Family

ID=22719572

Family Applications (1)

Application Number Title Priority Date Filing Date
FR944790A Expired FR3896M (fr) 1962-05-15 1963-08-11

Country Status (13)

Country Link
US (1) US3502699A (fr)
JP (1) JPS4812737B1 (fr)
AT (2) AT272532B (fr)
BR (1) BR6349095D0 (fr)
CH (1) CH494213A (fr)
DE (3) DE1468642B1 (fr)
DK (2) DK116056B (fr)
ES (2) ES288360A1 (fr)
FI (1) FI41741B (fr)
FR (1) FR3896M (fr)
IT (1) IT1061776B (fr)
NO (2) NO124598B (fr)
SE (5) SE323668B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723533A (en) * 1968-02-27 1973-03-27 American Cyanamid Co Substituted naphthalenone and naphthalenedione compounds
JPS5320840Y2 (fr) * 1973-11-21 1978-06-01
DE2718872A1 (de) * 1976-06-14 1977-12-22 Jenapharm Veb Verfahren zur herstellung von neuen gona-4,9(10)-dienen
FR2618783B1 (fr) * 1987-07-30 1991-02-01 Roussel Uclaf Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
WO2015057894A1 (fr) * 2013-10-15 2015-04-23 Massachusetts Institute Of Technology Méthodes de traitement d'une maladie polykystique rénale et d'une maladie polykystique du foie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069421A (en) * 1961-04-12 1962-12-18 Roussel Uclaf Process for the preparation of delta5(10)-estrene-17beta-ol-3-one and intermediates

Also Published As

Publication number Publication date
DE1793633C3 (de) 1973-10-04
DE1618973A1 (de) 1971-12-30
US3502699A (en) 1970-03-24
DE1793633A1 (de) 1971-12-30
NO124598B (fr) 1972-05-08
SE323669B (fr) 1970-05-11
BR6349095D0 (pt) 1973-08-02
AT283609B (de) 1970-08-10
DK114340B (da) 1969-06-23
CH494213A (de) 1970-07-31
DE1793633B2 (de) 1973-03-08
SE323668B (fr) 1970-05-11
IT1061776B (it) 1983-04-30
FI41741B (fr) 1969-10-31
DK116056B (da) 1969-12-08
AT272532B (de) 1969-07-10
ES288359A1 (es) 1963-12-01
JPS4812737B1 (fr) 1973-04-23
NO124597B (fr) 1972-05-08
DE1618973B2 (de) 1973-10-31
SE330164B (fr) 1970-11-09
SE330166B (fr) 1970-11-09
SE330165B (fr) 1970-11-09
ES288360A1 (es) 1963-12-01
DE1618973C3 (de) 1974-06-06
DE1468642B1 (de) 1971-03-11

Similar Documents

Publication Publication Date Title
FI41741B (fr)
BE616548R (fr)
BE613298A (fr)
BE613190A (fr)
BE613335A (fr)
BE633073A (fr)
BE632426A (fr)
BE631824A (fr)
BE631668A (fr)
BE630266A (fr)
BE628692A (fr)
BE628071A (fr)
BE627783A (fr)
BE635138A (fr)
BE627377A (fr)
BE625688A (fr)
BE616785A (fr)
BE616490A (fr)
BE616386A (fr)
BE616166A (fr)
BE615962A (fr)
BE615849A (fr)
BE615804A (fr)
BE615523A (fr)
BE615521A (fr)